Published in J Biol Chem on May 25, 2007
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience (2011) 1.62
Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons. J Neurochem (2008) 1.15
Calpain mediates proteolysis of the voltage-gated sodium channel alpha-subunit. J Neurosci (2009) 1.14
Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-aspartate receptor NR2B subunit in a phosphorylation-dependent manner. J Biol Chem (2007) 1.09
Post-translational modification biology of glutamate receptors and drug addiction. Front Neuroanat (2011) 1.07
Brain networks in Huntington disease. J Clin Invest (2011) 1.02
Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model. Hum Mol Genet (2012) 0.95
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Ann Clin Transl Neurol (2014) 0.93
Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis. Ann Clin Transl Neurol (2014) 0.92
Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons. Mol Brain (2010) 0.91
Ephrin-B3 regulates glutamate receptor signaling at hippocampal synapses. Mol Cell Neurosci (2010) 0.90
Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpression. Neurobiol Dis (2012) 0.90
N-methyl-D-aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunit. J Biol Chem (2011) 0.89
Developmental localization of NMDA receptors, Src and MAP kinases in mouse brain. Neurosci Lett (2011) 0.89
Roles of subunit phosphorylation in regulating glutamate receptor function. Eur J Pharmacol (2013) 0.88
Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons. J Biol Chem (2008) 0.88
Postsynaptic density-95 (PSD-95) and calcineurin control the sensitivity of N-methyl-D-aspartate receptors to calpain cleavage in cortical neurons. Mol Pharmacol (2008) 0.88
Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma. Cell Death Differ (2013) 0.88
Ethanol-induced increase in Fyn kinase activity in the dorsomedial striatum is associated with subcellular redistribution of protein tyrosine phosphatase α. J Neurochem (2011) 0.86
NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. J Neurochem (2011) 0.86
Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome. J Neuroimmunol (2015) 0.86
The ankyrin repeat-rich membrane spanning (ARMS)/Kidins220 scaffold protein is regulated by activity-dependent calpain proteolysis and modulates synaptic plasticity. J Biol Chem (2010) 0.86
Calpain and the glutamatergic synapse. Front Biosci (Schol Ed) (2009) 0.84
HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment. Am J Pathol (2010) 0.82
Tau-tubulin kinase. Front Mol Neurosci (2014) 0.81
FRET-FLIM investigation of PSD95-NMDA receptor interaction in dendritic spines; control by calpain, CaMKII and Src family kinase. PLoS One (2014) 0.80
Ca2+-dependent, stimulus-specific modulation of the plasma membrane Ca2+ pump in hippocampal neurons. J Neurophysiol (2009) 0.80
β-Estradiol unmasks metabotropic receptor-mediated metaplasticity of NMDA receptor transmission in the female rat dentate gyrus. Psychoneuroendocrinology (2012) 0.79
Calpain dysregulation in Alzheimer's disease. ISRN Biochem (2012) 0.79
Tyrosine phosphorylation of glutamate receptors by non-receptor tyrosine kinases: roles in depression-like behavior. Neurotransmitter (Houst) (2016) 0.77
Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning. J Neurosci (2012) 0.77
Presenilin-1/γ-secretase controls glutamate release, tyrosine phosphorylation, and surface expression of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B. J Biol Chem (2013) 0.77
Fyn in Neurodevelopment and Ischemic Brain Injury. Dev Neurosci (2015) 0.75
Higher levels of phosphorylated Y1472 on GluN2B subunits in the frontal cortex of aged mice are associated with good spatial reference memory, but not cognitive flexibility. Age (Dordr) (2016) 0.75
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem (1996) 10.08
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A (2002) 8.57
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci (2002) 7.57
Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (1992) 6.49
Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci (2000) 6.10
The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol (1987) 4.73
Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science (1992) 4.58
The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci (1999) 4.37
Molecular diversity of the NMDA receptor channel. Nature (1992) 3.76
The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron (2005) 2.68
Mobile NMDA receptors at hippocampal synapses. Neuron (2002) 2.67
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron (1996) 2.62
Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem (2001) 2.46
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem (1993) 2.30
Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell (1998) 2.21
Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition. Nat Neurosci (1998) 2.21
Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature (1992) 2.18
Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science (1997) 2.13
Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport (1992) 2.11
Memories of NMDA receptors and LTP. Trends Neurosci (1995) 1.76
The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. Proc Natl Acad Sci U S A (1994) 1.61
Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology (2003) 1.56
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther (2002) 1.52
Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol Pharmacol (2004) 1.46
Scaffolding of Fyn kinase to the NMDA receptor determines brain region sensitivity to ethanol. J Neurosci (2003) 1.44
N-methyl-D-aspartate receptors expressed in a nonneuronal cell line mediate subunit-specific increases in free intracellular calcium. J Biol Chem (1997) 1.32
Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J Neurosci (1996) 1.30
Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci (2003) 1.26
Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death. J Neurochem (1995) 1.25
Regulation of N-methyl-D-aspartate receptors by calpain in cortical neurons. J Biol Chem (2005) 1.21
Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem (2001) 1.20
N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J Biol Chem (2005) 1.16
Identification of mouse NMDA receptor subunit NR2A C-terminal tyrosine sites phosphorylated by coexpression with v-Src. J Neurochem (2001) 1.12
Tyrosine phosphorylation of the N-methyl-D-aspartate receptor by exogenous and postsynaptic density-associated Src-family kinases. J Neurochem (2001) 1.11
Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J Neurosci (1996) 1.10
NMDA receptor pharmacology: perspectives from molecular biology. Curr Drug Targets (2001) 1.08
Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J Neurosci (2004) 1.06
Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther (2002) 1.06
Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology (2003) 1.06
Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD-95. J Neurochem (2001) 1.01
The N-methyl-D-aspartate receptor subunits NR2A and NR2B bind to the SH2 domains of phospholipase C-gamma. J Neurochem (1997) 0.97
Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe. Biochem Biophys Res Commun (1989) 0.96
Platelet-derived growth factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of phosphatidylinositol 3-kinase. J Biol Chem (2000) 0.93
Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon2) subunit. Eur J Pharmacol (2001) 0.88
Developmental and cell-selective variations in N-methyl-D-aspartate receptor degradation by calpain. J Neurochem (2006) 0.86
The fyn art of N-methyl-D-aspartate receptor phosphorylation. Proc Natl Acad Sci U S A (1999) 0.85
Proteolysis of NR2B by calpain in the hippocampus of epileptic rats. Neuroreport (2005) 0.85
Translocation of human platelet calpain-I. Biochem Mol Biol Int (1993) 0.78
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci (2010) 6.44
A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol (2007) 4.63
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol (2009) 4.49
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist (2005) 3.11
Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci (2010) 2.30
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet (2008) 2.04
Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy. J Neurosci (2007) 2.00
The E46K mutation in alpha-synuclein increases amyloid fibril formation. J Biol Chem (2005) 1.98
Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia (2002) 1.91
FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann Neurol (2012) 1.83
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci (2012) 1.82
Massive and specific dysregulation of direct cortical input to the hippocampus in temporal lobe epilepsy. J Neurosci (2006) 1.71
A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J Neurosci (2002) 1.69
Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci (2007) 1.64
Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus. J Neurosci (2008) 1.63
Hippocampal CA1 circuitry dynamically gates direct cortical inputs preferentially at theta frequencies. J Neurosci (2005) 1.62
Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. J Biol Chem (2004) 1.58
Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1. J Neurosci (2006) 1.52
Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry (2004) 1.43
Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci (2006) 1.43
Clinical measures of dysarthria in Friedreich Ataxia. Mov Disord (2010) 1.43
Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J Neurosci (2006) 1.39
High-throughput immunoassay for the biochemical diagnosis of Friedreich ataxia in dried blood spots and whole blood. Clin Chem (2013) 1.39
Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A (2006) 1.38
Calpain and synaptic function. Mol Neurobiol (2006) 1.37
Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci (2013) 1.35
Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet (2012) 1.33
Mortality in Friedreich ataxia. J Neurol Sci (2011) 1.33
A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab (2010) 1.32
Evidence for a third sodium-binding site in glutamate transporters suggests an ion/substrate coupling model. Proc Natl Acad Sci U S A (2010) 1.29
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord (2010) 1.29
Repeated neonatal handling with maternal separation permanently alters hippocampal GABAA receptors and behavioral stress responses. Proc Natl Acad Sci U S A (2003) 1.28
AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem (2002) 1.27
Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci (2003) 1.26
Dentate granule cell GABA(A) receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur J Neurosci (2003) 1.26
In vitro functional imaging in brain slices using fast voltage-sensitive dye imaging combined with whole-cell patch recording. Nat Protoc (2008) 1.25
Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro. J Neurochem (2003) 1.22
Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector. PLoS One (2011) 1.21
Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. Neurobiol Dis (2006) 1.21
Long-term alterations in glutamate receptor and transporter expression following early-life seizures are associated with increased seizure susceptibility. J Neurochem (2004) 1.17
N-methyl-D-aspartate receptor subtype mediated bidirectional control of p38 mitogen-activated protein kinase. J Biol Chem (2005) 1.16
Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry (2005) 1.16
Hippocampal microcircuit dynamics probed using optical imaging approaches. J Physiol (2011) 1.14
Deterministic and stochastic neuronal contributions to distinct synchronous CA3 network bursts. J Neurosci (2012) 1.14
Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia (2002) 1.08
Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J Neurosci (2004) 1.06
Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther (2002) 1.06
Shift of intracellular chloride concentration in ganglion and amacrine cells of developing mouse retina. J Neurophysiol (2005) 1.05
Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments. Mol Genet Metab (2007) 1.04
Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). Am Heart J (2011) 1.01
Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion. Am J Med Genet A (2004) 1.00
Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol (2008) 0.98
Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J Neurochem (2007) 0.97
Protracted postnatal development of sparse, specific dentate granule cell activation in the mouse hippocampus. J Neurosci (2013) 0.97
Neuronal activity and glutamate uptake decrease mitochondrial mobility in astrocytes and position mitochondria near glutamate transporters. J Neurosci (2014) 0.97
Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion (2010) 0.96
Antioxidant use in Friedreich ataxia. J Neurol Sci (2007) 0.95
Analysis of echocardiograms in a large heterogeneous cohort of patients with friedreich ataxia. Am J Cardiol (2011) 0.94
Pharmacotherapy for Friedreich ataxia. CNS Drugs (2009) 0.94
Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome. Child Neuropsychol (2005) 0.94
A gene expression phenotype in lymphocytes from Friedreich ataxia patients. Ann Neurol (2011) 0.94
Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study. J Neurol (2011) 0.93
Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons. Proc Natl Acad Sci U S A (2010) 0.93
Therapeutic approaches for the treatment of Friedreich's ataxia. Expert Rev Neurother (2014) 0.91
miR-886-3p levels are elevated in Friedreich ataxia. J Neurosci (2012) 0.89
N-methyl-D-aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunit. J Biol Chem (2011) 0.89
Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol (2012) 0.89
Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia. PLoS One (2013) 0.89
Health related quality of life measures in Friedreich Ataxia. J Neurol Sci (2008) 0.87
Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS. Bioanalysis (2013) 0.87
Architecture of fully occupied GluA2 AMPA receptor-TARP complex elucidated by cryo-EM. Nature (2016) 0.87
Novel, complex interruptions of the GAA repeat in small, expanded alleles of two affected siblings with late-onset Friedreich ataxia. Mov Disord (2008) 0.86
N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. J Biol Chem (2007) 0.86
Global and local processing in adult humans (Homo sapiens), 5-year-old children (Homo sapiens), and adult cotton-top tamarins (Saguinus oedipus). J Comp Psychol (2006) 0.86
NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. J Neurochem (2011) 0.86
Developmental and cell-selective variations in N-methyl-D-aspartate receptor degradation by calpain. J Neurochem (2006) 0.86
Engraftment of nonintegrating neural stem cells differentially perturbs cortical activity in a dose-dependent manner. Mol Ther (2013) 0.85
The incorporation of an ion channel gene mutation associated with the long QT syndrome (Q9E-hMiRP1) in a plasmid vector for site-specific arrhythmia gene therapy: in vitro and in vivo feasibility studies. Hum Gene Ther (2003) 0.85
Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix). J Clin Neuromuscul Dis (2009) 0.85
Urinary isoprostanes in Friedreich ataxia: lack of correlation with disease features. Mov Disord (2008) 0.84
Cardiac neural regulation oscillates with the estrous cycle in freely moving female rats: the role of endogenous estrogens. Endocrinology (2010) 0.84
Calpain and the glutamatergic synapse. Front Biosci (Schol Ed) (2009) 0.84
Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database. Brain (2013) 0.84
Analysis of the visual system in Friedreich ataxia. J Neurol (2013) 0.83